Literature DB >> 7722130

Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.

J J Mahmarian1, A C Mahmarian, G F Marks, C M Pratt, M S Verani.   

Abstract

OBJECTIVES: This study prospectively evaluated whether early assessment with adenosine thallium-201 tomography could better refine risk stratification on the basis of absolute extent of myocardial ischemia in postinfarction patients in clinically stable condition.
BACKGROUND: Postinfarction patients are at increased risk for subsequent cardiac events. However, identifying high risk patients among those with residual myocardial ischemia is suboptimal.
METHODS: All 146 patients enrolled underwent assessment of left ventricular function and had adenosine tomography performed early (mean [+/- SD] 5 +/- 3 days) after infarction. Excluded from analysis were 51 patients with revascularization after scintigraphy and 3 lost to follow-up. Statistical risk models were therefore generated from the remaining 92 patients.
RESULTS: Cardiac events occurred in 30 (33%) of 92 patients over 15.7 +/- 4.9 months. Univariate predictors of all events were quantified perfusion defect size (p < 0.0001), absolute extent of left ventricular ischemia (p < 0.000001) and ejection fraction (p < 0.0001). Risk was best predicted by Cox analysis on the basis of 1) absolute extent of ischemia and ejection fraction (chi-square 24.6); 2) percent infarct zone ischemia and ejection fraction (chi-square 24.4); or 3) total perfusion defect size and percent infarct zone ischemia (chi-square 18.9). The variables that predicted all cardiac events were equally powerful at predicting only death and nonfatal reinfarction. Death was best predicted by total perfusion defect size.
CONCLUSIONS: Risk analysis of individual patients early after infarction is feasible on the basis of the quantified extent of scintigraphic ischemia and severity of left ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722130     DOI: 10.1016/0735-1097(95)00016-W

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

1.  Post-myocardial infarction risk stratification with stress nuclear myocardial perfusion imaging versus echocardiography: separate but not equal.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 3.  Radionuclide imaging in risk assessment after acute coronary syndromes.

Authors:  J E Udelson; E J Flint
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 4.  Assessment of prognosis in chronic coronary artery disease.

Authors:  T M Bateman; E Prvulovich
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 5.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

6.  Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal?

Authors:  Rami Doukky; Yasmeen Golzar
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

7.  The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

8.  Depressed heart rate response to vasodilator stress for myocardial SPECT predicts mortality in patients after myocardial infarction.

Authors:  Young Hwan Kim; Kyung-Han Lee; Hong Joo Chang; Eun Jeong Lee; Hyun Woo Chung; Joon Young Choi; Yong Choi; Yearn Seong Choe; Sang Hoon Lee; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2006-04-21       Impact factor: 2.357

9.  The troponin conundrum: clarification through stress myocardial perfusion SPECT.

Authors:  John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

10.  Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction.

Authors:  John J Mahmarian; Leslee J Shaw; Gerald H Olszewski; Bradley K Pounds; Maria E Frias; Craig M Pratt
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.